Treatment with T80/H25 was associated with a significantly greater mean reduction in BP compared with V160/H25 for both SBP (adjusted mean difference −2.7 mm Hg; 95% confidence interval (CI), −5.1, −0.3; P = 0.0265) and DBP (adjusted mean difference −2.0 mm Hg; 95% CI, −3.4, −0.6; P = 0.0041).
telmisartan 80 mg combined with hydrochlorothiazide (HCTZ) 25 mg
valsartan 160 mg combined with hydrochlorothiazide (HCTZ) 25 mg
reduction in BP for systolic blood pressure (SBP) and diastolic blood pressure (DBP) 